Distinguishing among functional neurological disorder, malingering, and factitious disorder relies primarily on careful examination of clinical features rather than on a single test or laboratory marker. Functional neurological disorder (FND) is characterized by neurological symptoms that are incongruent with recognized neurological disease, yet the symptoms are experienced as involuntary by the patient. In contrast, malingering and factitious disorder both involve deliberate production or exaggeration of symptoms, but for different reasons: in malingering, the motivation is external gain such as financial compensation or avoidance of duty, while in factitious disorder the motivation is internal, usually a psychological need to assume the sick role or to receive care and attention.
In FND, the hallmark clinical feature is internal inconsistency of symptoms over time and across contexts, along with positive signs that point to a functional mechanism rather than to structural damage. For example, patients with functional limb weakness may demonstrate a normal pattern of muscle activation when distracted, yet show marked weakness during formal strength testing. Similarly, functional tremor may vary in frequency and amplitude, entrain to voluntary rhythmic movements of another limb, or disappear with distraction. These “rule-in” signs are not typical of malingering or factitious disorder, where the symptom presentation is often more rigid, stereotyped, and designed to appear convincingly pathological at all times.
Another important feature of FND is that symptoms often cluster around common functional syndromes, such as functional seizures (psychogenic nonepileptic seizures), functional movement disorders, functional gait disturbance, and functional sensory loss. These syndromes have recognizable patterns: functional seizures may have prolonged duration, eye closure, asynchronous limb movements, or pelvic thrusting, and often lack postictal confusion and tongue biting characteristic of generalized tonic-clonic epileptic seizures. Functional gait disorders may present with excessive sway, dramatic “near falls,” or an ability to navigate obstacles better than expected given the apparent severity of impairment. Such patterns reflect the involvement of attention, expectation, and limbic processes rather than intentional feigning.
By contrast, individuals who are malingering tend to tailor their symptomatology to match what they believe clinicians expect to see, often based on lay or internet knowledge. Symptoms may be exaggerated in a way that is inconsistent with known anatomy or physiology, but with a recognizably goal-directed pattern. For example, a person seeking disability benefits might describe constant, unremitting pain at maximal intensity, with every movement worsening symptoms, yet show adequate functioning when unobserved. The complaints may be accompanied by overt anger about secondary gains being denied or by strong insistence on specific evaluations, letters, or legal-supporting documentation, which can signal the centrality of external incentives.
In factitious disorder, the production or falsification of symptoms is also intentional, but the clinical narrative differs in important ways. Patients may have an extensive medical history with multiple hospitalizations, invasive procedures, and consultations across different specialties. They often present with dramatic, complex symptom descriptions, sometimes with an almost theatrical quality. The history can be inconsistent, with discrepancies between verbal reports, prior records, and objective findings. Unlike malingering, the external gains are minimal or even negative, as patients frequently incur occupational, financial, and social costs from repeated medical care. The behavior appears driven by a psychological need to be ill, rather than by tangible rewards.
Physical examination findings can provide additional clues. In FND, there are often specific, reproducible signs that point toward a functional mechanism. Examples include Hoover’s sign in functional leg weakness, collapsing or “give-way” weakness, inconsistency between formal testing and observed function (such as a person unable to lift a leg in bed but later climbing onto an examination table), and nondermatomal sensory loss. These features suggest altered motor and sensory control due to changes in attention and expectation, not conscious deception. In malingering and factitious disorder, such classic functional signs may be absent, or the patient may attempt to mimic them in a crude or inconsistent fashion if they have learned about FND.
Symptom evolution over time also helps differentiate these conditions. In FND, symptom severity and pattern often fluctuate with stress, fatigue, emotional triggers, and contextual factors, but usually remain grounded in a coherent functional syndrome. The onset may follow physical injury, illness, or psychological stressors, and comorbid anxiety, depression, or trauma-related conditions are common. In malingering, the emergence or escalation of symptoms frequently aligns with specific external contingencies, such as pending litigation, workplace conflicts, or military or legal evaluations. Symptoms may rapidly improve or disappear when those contingencies change, for instance after a lawsuit is settled. In factitious disorder, symptom onset and exacerbations can appear around times when the person perceives declining attention or fears discharge from care, leading to new, often dramatic episodes that re-engage medical teams.
Patterns in healthcare utilization further distinguish these groups. People with FND may see many specialists in search of an explanation and often accept the reality of their symptoms, even if anxious or skeptical about the diagnosis. They may feel frustration when tests return normal, fearing that their symptoms are being dismissed as “all in the head.” Individuals with factitious disorder typically have a longer, more complex healthcare trajectory, sometimes spanning multiple institutions, with repeated workups for unusual or recurrent presentations. There may be evidence of doctor shopping, use of aliases, or vague explanations for prior hospitalizations. Malingering often becomes apparent in contexts where healthcare encounters are instrumental to external goals, such as occupational evaluations, insurance assessments, forensic settings, or correctional facilities; outside these contexts, utilization may diminish.
Laboratory and imaging results can be revealing, though not diagnostic in isolation. In FND, structural imaging and routine neurological tests are typically normal or show incidental findings not explaining the symptoms. Functional neuroimaging research has identified alterations in networks related to movement, emotion, and self-agency, but these methods are not used clinically for diagnosis. In factitious disorder, test results may show evidence of tampering or self-induced pathology, such as unexplained abnormal lab values, recurrent infections with unusual organisms, or detection of exogenous substances in blood or urine. By contrast, in malingering, laboratory and imaging studies are frequently normal or reveal only minor, non-disabling abnormalities, since the individual is not usually harming themselves to produce genuine pathology.
The person’s subjective experience and narrative of their symptoms play a significant role in differentiation. Patients with FND generally describe their symptoms as distressing, unwanted, and outside their control. They often express confusion and fear, and they may show ambivalence toward psychological explanations while being sincerely invested in understanding what is happening. Their accounts of daily functional impact—trouble working, social withdrawal, or difficulty with routine tasks—tend to be detailed and emotionally congruent. Those who are malingering may provide overly rehearsed or stereotyped descriptions, sometimes with incongruent affect, such as appearing bored or evasive when discussing supposedly severe and disabling symptoms. In factitious disorder, the narrative may contain intricate medical details, frequent references to rare diseases, or claims of prior complex treatments without verifiable records, with the person seeming oddly comfortable or even energized when discussing their medical history.
Behavioral observations during encounters can be particularly informative. In FND, unstructured moments—such as entering or leaving the exam room, or casual interaction during history-taking—may show better function than formal testing, but the improvements are involuntary and not linked to obvious external reinforcers. The person is usually not carefully monitoring whether they are being watched. In malingering, symptom display is often most pronounced when attention is clearly directed at the patient and may lessen when the individual believes they are unobserved. There can be a sense of performance, with abrupt shifts in behavior depending on audience and perceived payoff. In factitious disorder, patients may display intense eagerness for procedures, consent quickly to high-risk tests, or request specific interventions, appearing unusually invested in remaining within the patient role.
Psychiatric comorbidities show overlapping but distinct profiles. FND commonly co-occurs with anxiety, depression, trauma-related conditions, and other functional somatic syndromes such as irritable bowel syndrome or fibromyalgia, reflecting shared vulnerability factors in stress regulation, interoception, and expectation. Factitious disorder is often associated with personality pathology, early-life adversity, and disturbances in identity and attachment; self-harming or medically risky behaviors may also be present outside of the overtly fabricated symptoms. In malingering, comorbidities may exist but are not central to the clinical picture; the defining feature is the pragmatic, goal-driven use of symptom claims rather than a pervasive identity or relational pattern centered on illness.
Communication style with clinicians provides further differentiation. Patients with FND may oscillate between fear of serious disease and relief when catastrophic conditions are ruled out, yet they often show at least some willingness to consider functional explanations if presented respectfully and clearly. They may become distressed at any implication that they are “faking,” because their symptoms genuinely feel involuntary. Individuals who are malingering can be more adversarial, guarded, or preoccupied with outcomes such as disability status, financial awards, or the specifics of medical documentation that could support their claims. Those with factitious disorder may be ingratiating at first, then become defensive or disappear from follow-up if inconsistencies are gently explored or if access to intensive medical care is limited.
Across all three conditions, overlapping features can create diagnostic uncertainty. People with FND may legitimately have litigation, workers’ compensation claims, or other external stressors, which does not automatically imply malingering. Likewise, a person with factitious disorder may also have genuine medical or neurological disease, complicating the picture. Reliance on simplistic assumptions about motivation or character can lead to mislabeling and harm. For this reason, clinicians focus primarily on the positive clinical signs of FND and on careful, pattern-based observation rather than on speculative judgments about intent. The presence of established functional signs, typical symptom clusters, and congruent emotional and behavioral responses strengthens confidence in an FND diagnosis and differentiates it from conditions characterized by deliberate symptom falsification.
Ultimately, differentiation among functional neurological disorder, malingering, and factitious disorder depends on synthesizing information from history, examination, investigations, and longitudinal observation. Clinical features such as internal inconsistency with rule-in functional signs, recognizable functional syndromes, alignment of symptoms with external incentives, patterns of health care seeking, and the quality of the patient’s narrative and relational stance all contribute to this judgment. A structured and consistent approach to assessment and documentation helps maintain clarity, reduce bias, and support accurate recognition of these distinct conditions, each of which carries different implications for management and for the therapeutic relationship.
Assessment strategies and diagnostic tools
Assessment begins with a detailed, chronological history that explores the onset, evolution, and triggers of symptoms, previous evaluations, and the broader psychosocial context. Rather than asking primarily “why” questions about motives, clinicians focus on “how” symptoms behave over time and across circumstances. Establishing what the person was doing immediately before symptom onset, any precipitating medical or psychological events, and the sequence of evaluations and treatments allows patterns to emerge that may favor functional neurological disorder, malingering, or factitious disorder. Thorough review of prior records is crucial, as discrepancies between reported history and objective findings can provide important clues, especially in factitious disorder.
A structured interview format enhances the reliability of assessment. Clinicians typically start with an open-ended description of the main complaint, then move to targeted questions about frequency, duration, variability, and context. For functional neurological presentations, questions clarify whether episodes occur in specific situations, with particular emotional states, or after physiological stressors such as pain, sleep deprivation, or injury. When external benefits are possible, the interview also explores occupational, legal, and financial circumstances in a neutral, nonaccusatory manner. The goal is not to interrogate but to gather a comprehensive picture that permits inference about consistency, plausibility, and alignment with known neurophysiology.
Physical and neurological examination remain central diagnostic tools, particularly for confirming positive signs that support FND. Systematic testing of strength, coordination, sensation, gait, and movement under varying conditions allows clinicians to compare performance when the patient is attentive to symptoms versus when attention is diverted. Maneuvers such as Hoover’s sign, hip abductor sign, tremor entrainment, and evaluation of distractibility in functional seizures are applied in a stepwise fashion and carefully documented. These “rule-in” findings have greater value than the mere absence of structural abnormalities, because they positively indicate preserved capacity for normal movement and sensation that is inconsistently accessed in volitional ways.
Standard neurological investigations, including MRI, CT, EEG, EMG/nerve conduction studies, and laboratory panels, serve primarily to exclude structural or metabolic disease and to identify any comorbid pathology. In FND, results are usually normal or show incidental findings unrelated to the clinical picture. In suspected functional seizures, prolonged video-EEG monitoring during events is particularly informative, allowing direct correlation between behavior and electrophysiological activity. A captured event without epileptiform discharges supports a diagnosis of functional seizures when interpreted in the context of semiology and overall clinical features. Nonetheless, normal tests alone do not confirm FND, and abnormal results do not rule it out; interpretation always relies on integrated clinical reasoning.
In cases where factitious disorder is considered, assessment often extends beyond standard neurological testing to include targeted investigations that examine the plausibility and source of reported abnormalities. Unusual infection patterns, fluctuating laboratory values, or recurrent unexplained complications may trigger more detailed review of sample handling, access to medications or biological materials, and potential self-induced harm. Collaboration with laboratory medicine, pharmacy, and nursing can uncover tampering or surreptitious ingestion or injection. However, such inquiries must be handled discreetly and ethically; premature confrontation based on suspicion alone can destroy trust and may not prevent further self-harm.
Neuropsychological evaluation plays a key role when cognitive symptoms, functional memory complaints, or suspected exaggeration of deficits are present. Comprehensive testing assesses attention, memory, executive functions, processing speed, and effort. Performance validity tests (PVTs) and symptom validity tests (SVTs) are specifically designed to evaluate the credibility of test performance and self-reported symptoms. Consistent failure on multiple well-validated PVTs, in the absence of severe neurological injury, raises concern for noncredible performance and may point toward malingering in settings where clear external incentives exist. However, interpretation requires expertise, as factors such as fatigue, psychiatric distress, low education, or language barriers can affect performance. A single suboptimal validity score is not sufficient to label a person as malingering or deceptive.
Psychiatric and psychological assessments are often essential adjuncts to neurological evaluation, particularly because FND, malingering, and factitious disorder intersect with mood, anxiety, trauma history, personality structure, and coping styles. Semi-structured diagnostic interviews help identify comorbid conditions such as major depressive disorder, post-traumatic stress disorder, panic disorder, dissociative disorders, or personality disorders that may contribute to vulnerability for FND or factitious behaviors. In-depth exploration of identity, attachment patterns, and prior experiences of illness and caregiving can illuminate motivations for assuming a sick role or for seeking external gains, without requiring the clinician to prove conscious intent.
Standardized questionnaires and rating scales provide complementary, quantifiable data on symptom severity, functional impairment, and psychological distress. Instruments assessing somatic symptom burden, dissociation, health anxiety, and trauma exposure can characterize broader patterns typical of FND and related conditions. While these tools cannot distinguish conclusively among FND, malingering, and factitious disorder, they contextualize the presentation and help monitor change over time. Repeated administrations at follow-up visits can demonstrate whether reported symptom severity tracks with objective functional changes and treatment engagement.
Behavioral observation across multiple contexts and time points is another powerful diagnostic tool. Clinicians note how the person moves when entering and leaving the room, interacts during casual conversation, or navigates unstructured tasks, and then compare this behavior to performance during formal examination. In FND, inconsistencies often emerge naturally when the patient is distracted or emotionally engaged in discussion. In malingering, symptom display may modulate more strategically depending on who is present (clinician, evaluator, attorney, family member) and when perceived incentives are at stake. For factitious disorder, rapid shifts between crises and apparent stability, as well as unusual eagerness for invasive procedures, may surface over repeated contacts.
Collateral information from family members, caregivers, employers, or other treating professionals can clarify discrepancies between reported and observed functioning, though this must be gathered with appropriate consent and respect for confidentiality. Collateral accounts can confirm whether seizures, falls, or episodes occur as described, how the person manages daily activities, and whether symptom intensity correlates with situational demands. In suspected factitious disorder, collateral sources may reveal patterns of frequent relocations, repeated hospitalizations in different systems, or inconsistencies in personal history. When malingering is a concern, information from occupational health or legal documents can help identify the timing of symptom onset relative to potential external incentives.
Systematic documentation is critical throughout the assessment. Clinicians record specific observations, direct quotations, test findings, and the temporal relationship between symptoms and contextual factors, avoiding pejorative labels or speculative judgments about character. Detailed notes on positive FND signs, performance variability, test validity results, and collateral information support transparent clinical reasoning and protect both patient and clinician in complex or contested cases. When malingering or factitious disorder remains in the differential diagnosis, careful, factual documentation allows others involved in care or legal processes to understand the basis for concern without relying on ambiguous terms or insinuations.
Interdisciplinary case conferences enhance diagnostic clarity by bringing together neurologists, psychiatrists, psychologists, rehabilitation specialists, social workers, and sometimes ethics consultants. Joint review of history, examination findings, neuroimaging, neuropsychological data, and nursing observations can reveal converging or diverging impressions that a single clinician might miss. For example, nursing staff may have witnessed patterns of symptom fluctuation on the ward that align with a functional explanation, while psychology input may highlight noncredible cognitive test performance in a medicolegal context. These discussions encourage more balanced conclusions and help reduce bias toward premature attributions of deception.
Risk assessment is a necessary part of the evaluation, particularly in suspected factitious disorder, where self-harm may take the form of injecting contaminants, inducing hypoglycemia, or manipulating medical devices. Clinicians evaluate access to means, prior episodes of medically unexplained complications, and any history of self-injury or suicidal behavior. Even when malingering is suspected, it is important to assess for co-occurring depression, substance misuse, interpersonal violence, or other risks that may warrant intervention. The presence of intentional symptom production does not negate the possibility of genuine psychological distress or danger to self or others.
Throughout the process, communication with the patient is itself a key diagnostic and therapeutic tool. Clear, respectful explanations of the purpose of tests, the meaning of normal or abnormal results, and the rationale for focusing on function and safety rather than on proving deception can reduce defensiveness and foster collaboration. In FND, validating the reality of symptoms while introducing the concept of reversible functional changes often leads to relief and greater engagement. When concerns about malingering or factitious disorder arise, clinicians typically avoid direct accusations, instead emphasizing observed inconsistencies, the need to prioritize safe and appropriate care, and the limits of further invasive testing when risks outweigh benefits.
Longitudinal follow-up functions as an additional assessment strategy. Over time, clinicians can observe how symptoms respond to reassurance, education, rehabilitation, and psychosocial interventions. In FND, gradual improvement with targeted physiotherapy, psychotherapy, and self-management strategies supports the working diagnosis. In malingering, symptom trajectories may track closely with the status of legal or compensation claims, while in factitious disorder, new or shifting symptoms may appear whenever opportunities for intensive medical involvement wane. Ongoing reevaluation ensures that evolving clinical information can refine initial impressions and guide more accurate formulation.
Role of intent, awareness, and secondary gain
Intent, awareness, and secondary gain occupy a central place in differentiating functional neurological disorder from malingering and factitious disorder, but they are also the most difficult elements to assess with certainty. Intent refers to whether the person is deliberately producing or exaggerating symptoms. Awareness involves the degree to which the person consciously recognizes their role in symptom generation. Secondary gain denotes the benefits—both external and internal—that may follow from being ill. In practice, these constructs form overlapping continua rather than clear-cut categories, and clinicians must use them cautiously, supported by careful assessment, documentation, and communication.
In functional neurological disorder, the prevailing understanding is that symptoms are experienced as involuntary, even though they arise from altered patterns of attention, expectation, and motor control rather than from structural damage. Patients report a genuine sense that movements, sensations, or episodes “just happen” to them, often with surprise or fear when symptoms occur. Neurobiological research suggests disruptions in networks related to self-agency and motor intention, which can help explain how someone can appear to “choose” certain movements at a neural level without conscious awareness of doing so. Here, awareness of symptom production is low or absent, and any secondary gains tend to be incidental rather than driving the presentation.
In contrast, malingering is defined by intentional symptom production or exaggeration in the service of clear external incentives, such as financial compensation, avoidance of work or military duty, accessing medication, or evading legal responsibility. The individual is presumed to be aware that the symptoms are not genuine or not as severe as claimed and to be deliberately shaping their behavior accordingly. Awareness and intent are therefore central to the concept of malingering, with secondary gain—specifically external gain—being the primary motivator. Nonetheless, this intent cannot be directly observed; it is inferred from patterns of behavior, inconsistencies, contextual incentives, and test findings, which leaves room for uncertainty and potential bias.
Factitious disorder occupies a complex middle ground. Like malingering, it involves intentional fabrication, induction, or exaggeration of symptoms, but the primary motivation is internal rather than external. The person is driven by a psychological need to adopt the sick role, to receive caregiving, to feel special or important to medical staff, or to manage internal conflict through illness behavior. They may go to great lengths to create or worsen symptoms, including self-injury or tampering with tests, even when no tangible reward is evident and substantial personal costs are incurred. Awareness of symptom production is present—these behaviors do not occur by accident—but awareness of the underlying psychological motives may be limited or conflicted. Secondary gain here is largely internal, related to identity, attachment, and emotion regulation.
Because intent and awareness cannot be measured directly, clinicians must recognize that attributions about them are hypotheses rather than proven facts. A person with FND may also receive disability benefits or avoid certain responsibilities, and a person who is malingering may simultaneously experience distress and some degree of genuine symptoms. Similarly, individuals with factitious disorder may partially dissociate from their own deceptive behaviors or rationalize them in ways that obscure their conscious awareness. For these reasons, the mere presence of secondary gain—whether external or internal—does not, on its own, distinguish among FND, malingering, and factitious disorder. Instead, clinicians attend to how central and consistent those gains appear in shaping symptom patterns over time.
Secondary gain itself can be conceptualized at multiple levels. Primary gain refers to the intrapsychic relief obtained when psychological conflict is converted into physical symptoms, often outside awareness; this is most typically invoked in FND and factitious presentations. Secondary gain encompasses tangible benefits such as financial support, reduced demands, increased attention, or legal advantages, while tertiary gain describes benefits to others (for example, family members who receive support or respite because the patient is ill). In FND, primary gain and broader stress-regulation functions tend to be more prominent, with secondary and tertiary gains emerging as unintended consequences. In malingering, external secondary gains are central and goal-directed. In factitious disorder, internal psychological gains dominate, but secondary and tertiary gains can also be present in complex ways.
Awareness itself is best viewed not as a simple on/off switch but as a graded, fluctuating phenomenon. People may be fully aware that they are describing impossible symptoms but minimize the significance of this discrepancy, telling themselves they are “just emphasizing” their suffering. Others may realize they have, at times, deliberately intensified symptoms, yet at other moments feel genuinely overwhelmed and out of control. Dissociation, alexithymia (difficulty identifying and describing emotions), and long-standing patterns of emotional suppression can further cloud awareness of motives and bodily processes. Particularly in factitious disorder, there can be an oscillation between deliberate planning of deceptive acts and a sense of compulsion or inevitability, making it difficult even for the person to articulate how intentional their behavior truly is.
From a clinical standpoint, the question is not simply whether intent and awareness are present but how they function in the person’s overall psychological and social context. In FND, symptoms often appear to serve as a maladaptive but automatic coping response to overwhelming stress, trauma, or conflict, providing a nonverbal expression of distress or a temporary escape from intolerable demands. The person does not consciously choose this strategy, and when it is explained that symptoms relate to functional changes in the nervous system, they may feel both relief and confusion rather than guilt or embarrassment about being “caught” in deception. In malingering, by contrast, clarification of inconsistencies or the removal of external incentives often leads to abrupt changes in symptom presentation or disengagement from care, suggesting a more instrumental, strategic use of symptoms.
In factitious disorder, the role of illness in the person’s identity is often especially salient. Illness may function as a central organizing theme around which self-worth, relationships, and life structure are built. Being a patient provides a clear role, a script for interactions, and predictable attention from professionals who are perceived as caring and competent. Intentional symptom production or falsification thus becomes embedded in a broader narrative of need for connection and validation. The person may admit, sometimes tearfully, that they “don’t know why” they keep causing problems for themselves, reflecting partial awareness of their behaviors but limited insight into the underlying motives and alternatives.
In medicolegal or compensation settings, the stakes of attributing intent and secondary gain are particularly high. Clinicians may feel pressure—from systems, insurers, or legal parties—to make definitive statements about malingering, even when the evidence is ambiguous. Ethical practice demands restraint: conclusions about deliberate deception should be grounded in clear, reproducible indicators such as noncredible test performance, extreme discrepancies between claimed and observed ability, or documented manipulation of tests, and even then, reports should distinguish between clinical impressions and legal determinations. Clarity in documentation and communication is essential, with careful description of observed behaviors and objective findings rather than broad character judgments.
Within ordinary clinical practice, a more pragmatic approach focuses less on proving intent and more on guiding safe, appropriate care. For patients with FND, emphasizing that symptoms are real, common, and potentially reversible helps shift attention away from questions of blame and toward collaborative rehabilitation. When factitious disorder is suspected, the central concern becomes prevention of self-harm and unnecessary procedures while maintaining as much therapeutic engagement as possible, rather than exposing deception for its own sake. Where malingering is likely, clinicians prioritize accurate functional assessment, avoidance of excessive or risky interventions, and clear boundaries about the limits of medical certification, without engaging in confrontational debates about honesty.
An additional complexity is that secondary gain can change over time. A person who initially develops FND in the wake of trauma or illness may later find that disability benefits, reduced workplace stress, or increased family support become important stabilizing factors. Conversely, someone who begins by intentionally exaggerating a minor injury to secure time off work may, through chronic inactivity, social withdrawal, and reinforcement of illness behavior, develop entrenched functional symptoms that feel increasingly involuntary. This dynamic interplay underscores the need for longitudinal observation and willingness to revise the formulation as new information emerges, rather than assuming that early impressions about intent are definitive.
Family, cultural, and systemic influences also shape how intent and secondary gain manifest. In some families, illness is a primary route to receiving care or avoiding conflict, making symptom expression—whether functional, factitious, or feigned—a learned method of communication. Cultural beliefs about illness, disability, and authority can affect how openly people discuss motives and how they interpret the benefits and burdens of being unwell. Health care systems that inadvertently reward extensive testing or confer status based on rare diagnoses may reinforce factitious behaviors, while adversarial compensation frameworks can magnify the role of external gain in malingering. Recognizing these broader influences helps prevent overly individualistic or moralistic interpretations of behavior.
Because errors in judging intent can cause substantial harm—through stigmatization, denial of necessary care, or missed detection of dangerous self-harm—clinicians are advised to proceed with humility. When discussing functional explanations with patients, avoiding language that implies conscious fabrication is crucial. Instead of focusing on whether symptoms are “real” or “in the mind,” explanations highlight that the nervous system can malfunction in how it controls movement and sensation without structural damage, and that treatment targets these functional changes directly. When concerns about factitious disorder or malingering must be addressed with other professionals, communication emphasizes concrete observations, risks, and management strategies, not assumptions about moral character.
Ultimately, intent, awareness, and secondary gain provide a conceptual framework rather than a rigid diagnostic test. They help illuminate why different people present with similar symptoms for very different reasons, and why management approaches must be tailored accordingly. Used thoughtfully, these constructs guide clinicians toward compassionate, boundary-conscious care that acknowledges the possibility of both suffering and agency, while leaving room for complexity and change over time.
Ethical, legal, and communication considerations
Ethical considerations arise from the tension between providing compassionate care and protecting patients, clinicians, and systems from harm. When functional neurological disorder, malingering, or factitious disorder is suspected, the risk of stigmatizing labels and iatrogenic damage is high. Ethics demands that clinicians prioritize nonmaleficence by avoiding unnecessary procedures, invasive tests, and confrontational interactions that may worsen symptoms or provoke self-harm. At the same time, beneficence requires active efforts to relieve suffering, including clear explanations, evidence-based treatment offers, and attention to comorbid psychiatric conditions, rather than withdrawing care because the etiology of symptoms is complex or uncomfortable.
Respect for autonomy is central but nuanced in this context. Patients with FND generally retain full decision-making capacity, yet their understanding of symptom mechanisms may be limited by prior miscommunication or by entrenched beliefs about illness. When factitious disorder is present, behavior can appear deceptive or manipulative, but this does not automatically negate capacity; instead, it calls for careful evaluation of whether the person can grasp the nature and consequences of their actions and proposed treatments. In rare cases, such as severe self-harm to induce illness or endangerment of dependents in factitious disorder imposed on another, temporary limitations on autonomy through involuntary hospitalization or child protection measures may be ethically justified to prevent serious harm.
Justice—fair and equitable allocation of healthcare resources—also comes into play. Repeated hospitalizations, high-cost investigations, and extensive consultations are common in FND and can be even more pronounced in factitious disorder. While clinicians may feel frustration about resource use, ethical practice avoids punitive responses. Instead, services can be structured to channel care toward interventions with clear benefit (such as specialized FND clinics, psychotherapy, and rehabilitation) and away from repeated low-yield testing. Transparent institutional policies on repeat admissions, cross-institution record sharing, and multidisciplinary review help maintain fairness while still recognizing the legitimacy of the patient’s suffering.
Legal considerations vary by jurisdiction but typically focus on capacity, duty of care, and mandatory reporting obligations. Clinicians must ensure that individuals with FND, malingering, or factitious disorder understand the information necessary to consent to or refuse treatments, including the risks of further investigations. When patterns of self-induced harm, tampering with devices, or fabricated symptoms lead to significant medical risk, documentation of risk assessment and the rationale for management decisions becomes vital, both for patient safety and for medico-legal protection. In cases of suspected factitious disorder imposed on another (formerly Munchausen by proxy), clinicians have a legal duty in many regions to report concerns to child protective services or vulnerable adult agencies, even if evidence is still emerging.
Workplace, insurance, and forensic contexts introduce additional legal complexity. When malingering is suspected in relation to compensation, disability, or criminal responsibility, clinicians may be asked to provide opinions about functional capacity or credibility. Ethical and legal standards require clear separation between clinical care and forensic roles whenever possible. If a clinician serves in an evaluative, non-treating capacity, this should be explained to the examinee, and the limitations of confidentiality and the intended use of the report must be explicitly stated. Reports should emphasize observed behaviors, test results, and clinical reasoning rather than definitive pronouncements on “truthfulness,” recognizing that determinations of fraud or liability ultimately belong to legal authorities, not clinicians.
Confidentiality remains a core obligation, but it is not absolute. Sharing information among treating providers is generally permitted when necessary for safe, coordinated care, especially in complex cases of FND, malingering, or factitious disorder with frequent emergency visits or hospitalizations. However, broader disclosures—to employers, insurers, legal representatives, or family members—typically require explicit patient consent unless there is a clear statutory exception. When a patient asks that certain information about suspected factitious behavior or self-harm be kept secret, clinicians must balance respect for privacy with duties to protect the patient or others from serious, foreseeable harm, documenting the reasoning and decisions in detail.
Thorough, neutral documentation serves as both an ethical and legal safeguard. Clinicians avoid pejorative language such as “faker,” “manipulative,” or “attention-seeking” and instead use descriptive terms like “inconsistencies observed,” “symptoms incongruent with examination findings,” or “concern for possible factitious disorder or malingering based on X, Y, and Z.” Notes should record specific behaviors (for example, walking steadily when leaving the room after demonstrating marked gait disturbance during formal testing), results of assessment tools, collateral information, and discussions about risk, treatment options, and boundaries. This level of documentation supports continuity of care, informs other clinicians without prejudicing them unduly, and provides a clear record if disputes or complaints arise.
Communication with patients about functional diagnoses and about concerns related to symptom validity requires careful planning and skill. For FND, explanations emphasize that the symptoms are real, common, and rooted in functional changes in brain and body networks, not imagined or “faked.” Phrasing such as “your tests show that the structure of your nervous system is intact, but the way it is controlling movement and sensation is altered in a way we can often treat” validates experience while introducing a hopeful, mechanistic understanding. Avoiding the implication that symptoms are “all psychological” or under voluntary control helps prevent shame and defensiveness, facilitating engagement in treatment.
When there is concern for factitious disorder, direct confrontation about deception often leads to denial, rupture of the therapeutic relationship, and escalation of risky behaviors. A more ethically grounded approach focuses conversations on safety, appropriate levels of medical intervention, and the availability of psychological support. Clinicians may say, for example, that “some of the findings and test results raise questions we do not fully understand, and our priority is to keep you safe and avoid procedures that may harm you while still taking your distress seriously.” This allows for limit-setting—such as declining further invasive tests—while leaving a door open for ongoing care and eventual disclosure should the patient choose.
Addressing suspected malingering poses its own communication challenges. In strictly clinical settings, it is rarely productive to directly accuse someone of lying, as this tends to polarize interactions and may lead to complaints or even legal action. Instead, clinicians can focus on function and treatment: explaining what can be supported based on objective findings, what restrictions or certifications are not clinically justified, and what interventions are likely to be helpful. In forensic or occupational assessments, communication may be more formal and structured, with clear explanation of the evaluator’s neutral role and the use of validity measures. Even in these contexts, sticking to data, avoiding inflammatory labels, and clearly distinguishing between clinical impressions and legal conclusions protects both patient rights and professional integrity.
Interprofessional communication is equally important. Complex cases typically involve neurologists, psychiatrists, psychologists, rehabilitation professionals, primary care clinicians, nurses, and sometimes legal or risk-management personnel. Regular case conferences and written summaries help align understanding, reduce contradictory messaging to the patient, and prevent fragmentation of care. When discussing suspicions of factitious disorder or malingering among professionals, teams should adhere to the same ethical standards as in documentation: focus on behaviors and findings, not character judgments, and remain open to alternative explanations or evolving information. Inclusion of ethics consultation can be especially helpful when self-harm risk, child protection issues, or major treatment limitations are under consideration.
Boundary setting lies at the intersection of ethics, law, and communication. Clear boundaries around prescriptions (such as controlled substances), repeat imaging, hospital admissions, and access to specialized procedures help prevent harm and maintain trust. These limits should be explained in a consistent, non-punitive way: “We do not think more scans will help and they could expose you to risk; instead, we recommend focusing on rehabilitation and therapy, which have better evidence of benefit for your type of symptoms.” Documenting these boundary discussions and ensuring that all members of the team adhere to them reduces opportunities for splitting or doctor-shopping and provides a defensible, patient-centered rationale for decisions.
Involvement of family members and caregivers requires sensitive communication and clear role definition. Families may feel confused, angry, or guilty when they hear that symptoms are “functional” or that factitious disorder or malingering is being considered. With the patient’s consent, clinicians can provide education about FND as a brain-based functional condition, emphasizing that support for rehabilitation, pacing, and normal routines is more helpful than excessive assistance or reinforcement of disability. In suspected factitious disorder imposed on another, communication with caregivers must be guided by legal and child-protection frameworks; discussions often occur in parallel with investigative agencies and may be restricted in what can be shared to avoid compromising safety or ongoing inquiries.
Training and institutional culture strongly influence how clinicians navigate these ethical, legal, and communication dilemmas. Without explicit education about FND, malingering, and factitious disorder, staff may fall back on stigmatizing narratives or inconsistent practices. Incorporating case-based teaching on clinical ethics, risk management, and effective communication strategies into neurology, psychiatry, emergency medicine, and primary care curricula can improve confidence and reduce variability. Institutions can support this by developing guidelines for assessment, documentation, and communication, clarifying when to involve psychiatry, ethics, legal counsel, and child-protection teams, and encouraging reflective discussion rather than blame when challenging cases arise.
Across all of these domains, a unifying principle is to hold complexity and uncertainty openly rather than collapsing prematurely into simple moral judgments. Symptoms that appear non-organic or inconsistent do not automatically imply malingering or factitious disorder, and even where deception plays a role, there is often profound underlying distress. Ethics, law, and communication practices that foreground safety, respect, and transparency—while still allowing for firm boundaries and appropriate skepticism—offer the best chance of protecting patients and maintaining professional integrity in the face of these demanding clinical situations.
Implications for treatment planning and care coordination
Treatment planning begins with a precise formulation that distinguishes functional neurological disorder from malingering and factitious disorder, because each has different therapeutic priorities, realistic goals, and risks. For FND, the central aim is symptom reduction and restoration of function through targeted rehabilitation and psychological interventions. In suspected factitious disorder, the focus shifts toward safety, containment of self-harm and iatrogenic harm, and gradual engagement in mental health care. When malingering is likely, the priority is appropriate, proportionate medical care that avoids unnecessary investigations and treatments, alongside clear boundary setting around certification, work restrictions, or disability claims. Starting from a shared multidisciplinary formulation ensures that the care plan is coherent, ethically sound, and aligned with available resources.
For FND, a structured explanation of the diagnosis is itself a core therapeutic intervention and sets the stage for successful treatment planning. This explanation highlights positive clinical signs and examination findings that demonstrate how symptoms are due to disrupted brain network functioning rather than structural damage. Once a patient understands that symptoms are real, common, and potentially reversible, clinicians can propose a stepwise plan that may include FND-informed physiotherapy, occupational therapy, speech and language therapy, and psychological treatment such as cognitive-behavioral therapy or trauma-focused approaches where appropriate. Clear communication of the rationale for each modality helps counter previous experiences of dismissal and fosters a collaborative stance that is essential for engagement.
In designing rehabilitation programs for FND, interdisciplinary coordination is crucial. Physiotherapists and occupational therapists trained in FND-specific principles prioritize retraining automatic movement and normal patterns of function, using techniques such as distraction, graded exposure to feared activities, and positive reinforcement of normal movement. Psychologists or psychiatrists address comorbid anxiety, depression, trauma, and maladaptive coping, helping patients manage triggers and reinterpret bodily sensations. Neurologists provide ongoing medical oversight, monitor for emerging organic pathology, and reinforce the functional formulation at follow-up visits. Regular case conferences allow the team to share observations, refine goals, and maintain consistent messaging so that the patient does not receive conflicting explanations or advice from different clinicians.
Goal setting for FND is best framed in terms of meaningful functional outcomes rather than complete symptom eradication, at least initially. Examples include returning to part-time work, walking independently for specific distances, reducing seizure-like episodes to a manageable frequency, or resuming key social or caregiving roles. Breaking these into graded steps supports pacing and reduces the risk of boom-and-bust patterns in activity. Shared decision-making ensures that goals reflect the patient’s values and context, increasing motivation and adherence. Transparent discussion about possible obstacles—such as fatigue, flare-ups, or comorbid pain conditions—helps normalize setbacks and prevents premature abandonment of treatment when progress is nonlinear.
When factitious disorder is suspected, treatment planning must carefully balance empathy with firm limits to prevent harm. The immediate priorities are to identify and reduce avenues for self-injury or tampering with tests and treatments, to limit unnecessary invasive procedures, and to establish safe, predictable patterns of care. This often involves concentrating medical oversight within a small, coordinated team that can monitor patterns over time and provide consistent responses to new symptoms. Frequent emergency visits or hospitalizations may be replaced with structured outpatient follow-up and clear crisis plans, thereby reducing the reinforcement of acute, dramatic presentations that lead to extensive investigations.
Engagement in psychotherapy for factitious disorder is typically gradual and ambivalent. Initial treatment planning may focus less on direct exploration of deceptive behaviors and more on building a stable therapeutic relationship, addressing overt crises, and enhancing emotional regulation. Approaches that incorporate elements of psychodynamic therapy, mentalization-based treatment, or schema-focused therapy can be helpful when personality pathology and attachment disturbances are prominent. Over time, if trust develops, therapy can gently explore the role that illness occupies in the person’s identity and relationships, alongside healthier ways to seek care and validation. Throughout this process, the medical team coordinates with mental health providers so that limit-setting around tests and admissions is framed as part of a unified, supportive strategy rather than as punishment for suspected deception.
For individuals in whom malingering is strongly suspected, treatment planning emphasizes ethical stewardship of resources, patient safety, and clear boundaries. Clinicians continue to address genuine health needs, provide evidence-based symptom management where appropriate, and ensure that comorbid psychiatric or substance use disorders are not neglected. However, requests for repeated high-risk procedures, long-term opioid prescribing without clear indication, or extensive documentation supporting severe disability in the absence of objective correlates are politely but firmly declined. Written summaries that describe functional capacity, observed inconsistencies, and assessment findings help guide non-medical decision-makers—such as employers, insurers, or courts—without forcing clinicians into the role of arbiter of truthfulness.
Across all three conditions, communication strategies need to be carefully calibrated to maintain a working alliance while honoring clinical priorities. In FND, language that emphasizes “retraining” the nervous system and regaining control of movement and sensation encourages active participation and counters feelings of helplessness. Therapeutic optimism is important but must be realistic; clinicians avoid promising complete recovery on a fixed timeline, instead highlighting that many people improve with focused treatment and that progress can continue over months to years. In factitious disorder, communication emphasizes concern for safety and a desire to understand the person’s distress, while making it clear that certain medical interventions will no longer be pursued because risks outweigh benefits. With suspected malingering, discussions focus on what care can justifiably be provided based on clinical findings, avoiding confrontational arguments about motivation.
Care coordination mechanisms provide the infrastructure that makes these communication strategies and treatment plans sustainable. A designated lead clinician—often a neurologist, psychiatrist, or primary care provider—can serve as the main contact for the patient and for other professionals, helping to align recommendations and reduce fragmentation. Shared care plans documented in the medical record outline the agreed diagnosis, key clinical findings, current treatment modalities, boundaries around investigations and prescriptions, and instructions for unscheduled presentations, such as emergency department visits for functional seizures. Making these plans easily accessible to on-call and emergency staff prevents repeated cycles of extensive workup and conflicting explanations when the patient presents to different parts of the system.
Integration of community resources is another important component of coordinated care. Social workers can assist with navigating benefits, workplace accommodations, transportation, and housing instability, all of which may influence symptom trajectories and treatment adherence. Vocational rehabilitation specialists can help patients with FND plan graded returns to work or identify alternative roles when previous occupations are no longer feasible. In school-aged patients, coordination with educational services allows for tailored accommodations that support participation without reinforcing disability. When malingering is suspected in the context of compensation or legal disputes, social and legal supports may be involved to clarify expectations and minimize adversarial dynamics without requiring clinicians to step outside their expertise.
Documentation practices directly support treatment planning and care coordination, especially in complex or high-risk presentations. Detailed notes that capture positive FND signs, patterns of symptom variability, results of performance validity tests, and episodes of suspected self-induced harm help the broader team understand the basis for diagnosis and management decisions. Clear records of prior discussions about boundaries (for example, decisions to limit further imaging or to centralize prescribing) reduce the likelihood that subsequent providers will inadvertently undermine the plan. In cases involving factitious disorder or malingering, precise, behaviorally anchored documentation protects patients from unfair labeling and clinicians from legal vulnerability, while allowing institutional leaders to identify patterns that may require system-level responses.
Follow-up schedules and monitoring plans are integral parts of treatment. For FND, regular follow-up visits—initially more frequent, then gradually spaced out—allow clinicians to track progress, adjust rehabilitation intensity, address new stressors, and reinforce functional gains. Symptom diaries, activity logs, and standardized outcome measures can make improvements more visible to both patient and provider, countering the perception that “nothing is changing” when progress is gradual. In factitious disorder, closer monitoring may be needed to detect new self-harming behaviors or sudden shifts in presentation that signal escalating risk. For suspected malingering, scheduled reviews focus on objective function and adherence to agreed interventions, ensuring that medical involvement remains appropriate in scope and duration.
Transitions of care represent moments of particular vulnerability and require proactive planning. When patients with FND move from inpatient to outpatient services, from specialized clinics to primary care, or from pediatric to adult services, detailed handovers that include the functional formulation, current gains, and active treatment components help prevent regression or reversion to diagnostic uncertainty. For individuals with factitious disorder, changes in care setting can trigger renewed efforts to seek intensive medical attention or to establish new provider relationships; anticipating this pattern, teams can coordinate introductions to receiving clinicians and share clear guidelines on handling new presentations. In medicolegal contexts where malingering has been considered, transitions such as discharge from rehabilitation or completion of an independent medical evaluation should be accompanied by well-structured reports that summarize findings and clarify the limits of medical opinion.
Education of patients and families is a cross-cutting theme in treatment planning. For FND, written materials, reputable websites, and group education sessions reinforce the explanation of functional mechanisms and available treatments, reducing reliance on inaccurate online sources. Families learn how to support graded independence, respond to episodes such as functional seizures, and avoid inadvertently reinforcing disability through overprotection or excessive assistance. In suspected factitious disorder, family education may be limited initially due to confidentiality and the risk of escalating conflict, but over time, psychoeducation about emotional regulation, attachment, and healthier care-seeking patterns can be offered when appropriate. When malingering is suspected, direct family education about the diagnosis may not be central, but families may still benefit from guidance on realistic expectations and safety concerns.
Institutional support and clinician training are essential to sustain effective treatment planning and coordination for these challenging conditions. Hospitals and clinics can develop protocols for managing functional seizures in emergency departments, guidelines for when to involve psychiatry or ethics consultation in recurrent unexplained presentations, and pathways for referral to specialized FND services. Regular interdisciplinary teaching sessions and morbidity-and-mortality style reviews of complex cases encourage reflection on how assessment, communication, and management decisions influenced outcomes. By normalizing discussion of FND, malingering, and factitious disorder within routine professional development, institutions reduce stigma and enhance clinicians’ confidence in delivering consistent, compassionate, and boundary-conscious care.
Ultimately, the implications of distinguishing FND from malingering and factitious disorder extend far beyond labeling; they shape which treatments are offered, how hope is framed, how risk is managed, and how teams collaborate. Thoughtful integration of formulation, ethics, communication, and system-level coordination allows clinicians to provide care that is both humane and realistic, responsive to suffering yet mindful of safety and resource stewardship, and flexible enough to adapt as new information and clinical changes emerge over time.
